A Systematic Review: The use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy

Haemophilia

Volumn 18, Issue 1, 2012, Pages 25-33

  Trigg, D E ^a   Stergiotou, I ^a   Peitsidis, P ^a   Kadir, R A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Delivery; Desmopressin; Haemophilia; Pregnancy; Safety; Von Willebrand's disease

Indexed keywords

DESMOPRESSIN; FRESH FROZEN PLASMA; METHYLERGOMETRINE; OXYTOCIN; TRANEXAMIC ACID;

ABSENCE OF SIDE EFFECTS; BERNARD SOULIER DISEASE; BIRTH WEIGHT; BLEEDING; BLEEDING DISORDER; CESAREAN SECTION; CHEMOPROPHYLAXIS; CHILDBIRTH; CRYOPRECIPITATE; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EHLERS DANLOS SYNDROME; ERYTHROCYTE TRANSFUSION; FEMALE; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; FLUSHING; GRAND MAL SEIZURE; HEADACHE; HEMOPHILIA; HEMOPHILIA A; HEMOSTASIS; HUMAN; HYPONATREMIA; LABOR INDUCTION; MEMBRANE RUPTURE; OCULAR ALBINISM; PERINATAL PERIOD; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREMATURE LABOR; PRENATAL PERIOD; PRIORITY JOURNAL; REVIEW; SECOND TRIMESTER PREGNANCY; SEIZURE; SIDE EFFECT; SOLUTIO PLACENTAE; SYSTEMATIC REVIEW; THROMBOCYTE DISORDER; THROMBOCYTE TRANSFUSION; TREATMENT INDICATION; VAGINAL DELIVERY; VON WILLEBRAND DISEASE; WATER INTOXICATION SEIZURE;

BLOOD COAGULATION DISORDERS; DEAMINO ARGININE VASOPRESSIN; FEMALE; HEMOSTATICS; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 84355166747     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2011.02573.x     Document Type: Review

References (45)

1. National Heart, Lung, and Blood Institute. The Diagnosis, Evaluation, and Management ofvon Willebrand Disease. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, 2007. Available at:
2. Mannucci PM, Canciani MT, Rota L, Donovan BS. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease. Br J Haematol 1981; 47: 283-93.
3. Kleiman SJ, Wiesel S, Tessler MJ. Patient-controlled analgesia (PCA) using fentanyl in a parturient with a platelet function abnormality. Can J Anaesth 1991; 38(4 Pt 1): 489-91.
4. Lethagen S. Desmopressin in the treatment of women's bleeding disorders. Haemophilia 1999; 5: 233-7.
5. Rahman SS, Myers JE, Gillham JC, Fitzmaurice R, Johnston TA. Post partum haemorrhage secondary to uterine atony, complicated by platelet storage pool disease and partial placenta diffusa: a case report. Cases J 2008; 1: 393.
6. Ray JG. DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstet Gynecol Surv 1998; 53: 450-5.
7. Bjoring A, Baxi L. Use of DDAVP as prophylaxis against postpartum hemorrhage in women with von Willebrand's disease: a case series demonstrating safety and efficacy. J Womens Health (Larchmt) 2004; 13: 845-7.
8. Mannucci PM. Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women. Blood 2005; 105: 3382.
9. Conti M, Mari D, Conti E, Muggiasca ML, Mannucci PM. Pregnancy in women with different types of von Willebrand disease. Obstet Gynecol 1986; 68: 282-5.
10. Chediak JR, Alban GM, Maxey B. von Willebrand's disease and pregnancy: management during delivery and outcome of offspring. Am J Obstet Gynecol 1986; 155: 618-24.
11. Gojnic M, Fazlagic A, Likic I et al. New approach of the treatment of von Willebrand's disease during pregnancy. Arch Gynecol Obstet 2005; 273: 35-8.
12. Castaman G, Federici AB, Bernardi M, Moroni B, Bertoncello K, Rodeghiero F. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect. J Thromb Haemost 2006; 4: 357-60.
13. Schulman S, Johnsson H, Egberg N, Blombäck M. DDAVP-induced correction of prolonged bleeding time in patients with congenital platelet function defects. Thromb Res 1987; 45: 165-74.
14. Castaman G, Tosetto A, Rodeghiero F. Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations. Haematologica 2010; 95: 963-9.
15. Sánchez-Luceros A, Meschengieser SS, Turdó K et al. Evaluation of the clinical safety of desmopressin during pregnancy in women with a low plasmatic von Willebrand factor level and bleeding history. Thromb Res 2007; 120: 387-90.
16. Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 1998; 105: 314-21.
17. Kadir RA, Economides DL, Braithwaite J, Goldman E, Lee CA. The obstetric experience of carriers of haemophilia. Br J Obstet Gynaecol 1997; 104: 803-10.
18. Ito M, Yoshimura K, Toyoda N, Wada H. Pregnancy and delivery in patients with von Willebrand's disease. J Obstet Gynaecol Res 1997; 23: 37-43.
19. Ramsahoye BH, Davies SV, Dasani H, Pearson JF. Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a reivesw of the literature. Haemophilia 1995; 1: 140-4.
20. Castaman G, Eikenboom JC, Contri A, Rodeghiero F. Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F. Thromb Haemost 2000; 84: 351-2.
21. Weinbaum PJ, Cassidy SB, Campbell WA et al. Pregnancy management and successful outcome of Ehlers-Danlos syndrome type IV. Am J Perinatol 1987; 4: 134-7.
22. Zatik J, Póka R, Borsos A, Pfliegler G. Variable response of Hermansky-Pudlak syndrome to prophylactic administration of 1-desamino 8D-arginine in subsequent pregnancies. Eur J Obstet Gynecol Reprod Biol 2002; 104: 165-6.
23. Beesley RD, Robinson RD, Stewart TL. Two successful vaginal births after cesarean section in a patient with Hermansky-Pudlak syndrome who was treated with 1-deamino-8-arginine-vasopression during labor. Mil Med 2008; 173: 1048-9.
24. Charles K, Preston F, Makris M. Successful use of desmopressin (DDAVP) in women with inherited storage pool disease. Haemophilia 2000; 6: 241-7 (abstract).
25. Heslop HE, Hickton CM, Laird E, Tait JD, Doig JR, Beard EJ. Twin pregnancy and parturition in a patient with the Bernard Soulier syndrome. Scand J Haematol 1986; 37: 71-3.
26. Naorose-Abidi SM, Bond LR, Chitolie A, Bevan DH. Desmopressin therapy in patients with acquired factor VIII inhibitors. Lancet 1988; 1: 366.
27. Peaceman AM, Katz AR, Laville M. Bernard-Soulier syndrome complicating pregnancy: a case report. Obstet Gynecol 1989; 73(3 Pt 2): 457-9.
28. Porteous AOR, Appleton DS, Hoveyda F, Lees CC. Acquired haemophilia and postpartum haemorrhage treated with internal pudendal embolisation. BJOG 2005; 112: 678-9.
29. Greinacher A, Pötzsch B, Kiefel V, White JG, Müller-Berghaus G, Mueller-Eckhardt C. Evidence that DDAVP transiently improves hemostasis in Bernard-Soulier syndrome independent of von Willebrand-factor. Ann Hematol 1993; 67: 149-50.
30. Fragneto RY, Datta S. Epidural analgesia in a preeclamptic parturient after normalization of a prolonged bleeding time with DDAVP. Reg Anesth 1995; 20: 448-51.
31. Kailash F, Wilkerson D. von Willebr and disease, pregnancy and neuraxial anesthesia: a multi-disciplinary approach for successful regional anesthesia. J Ark Med Soc 2009; 105: 259-60, 262.
32. Rochelson B, Caruso R, Davenport D, Kaelber A. The use of prophylactic desmopressin (DDAVP) in labor to prevent hemorrhage in a patient with Ehlers-Danlos syndrome. N Y State J Med 1991; 91: 268-9.
33. Miki T, Oh H, Hirasawa A et al. Prophylactic use of DDAVP in a patient with von Willebrand disease during labor: a case report and a review. Rinsho Ketsueki 1990; 31: 325-9.
34. Poddar RK, Coley S, Pavord S. Hermansky-Pudlak syndrome in a pregnant patient. Br J Anaesth 2004; 93: 740-2.
35. Lee CA, Chi C, Pavord SR et al. The obstetric and gynaecological management of women with inherited bleeding disorders - review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization. Haemophilia 2006; 12: 301-36.
36. Mangel J, Laudenbach L, Schembri S, Jardine L, Lohmann R. DDAVP at a maximal dose of 15μg administered subcutaneously is a safe and effective alternative to 20μg IV for patients >50kg with von Willebrand disease or mild hemophilia A. ASH Annual Meeting Abstracts 2005; 106: 1793 (abstract).
37. Rodeghiero F, Castaman G, Mannucci PM. Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A. Thromb Haemost 1996; 76: 692-6.
38. Lethagen S, Harris AS, Sjörin E, Nilsson IM. Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility. Thromb Haemost 1987; 58: 1033-6.
39. Federici AB. The use of desmopressin in von Willebrand disease: the experience of the first 30years (1977-2007). Haemophilia 2008; 14(Suppl 1): 5-14.
40. Joint Formulary Committee. British National Formulary. 58th edn. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2009.
41. Mannucci PM. Desmopressin: a nontransfusional hemostatic agent. Annu Rev Med 1990; 41: 55-64.
42. Mercorio F. Effectiveness and mechanism of action of desmopressin in the treatment of copper intrauterine device-related menorrhagia: a pilot study. Hum Reprod 2003; 18: 2319-22.
43. Burrow GN, Wassenaar W, Robertson GL, Sehl H. DDAVP treatment of diabetes insipidus during pregnancy and the post-partum period. Acta Endocrinol 1981; 97: 23-5.
44. Hale T. Medications and Mother's Milk, 13th edn. Amarillo, TX: Hale Publishing, 2008.
45. Ferring S. Switzerland, TGA approved. 1993.